Literature DB >> 19295334

Racial differences in changes of metabolic parameters and body composition in antiretroviral therapy-naive persons initiating antiretroviral therapy.

Cynthia L Gibert1, Judith C Shlay, Shweta Sharma, Glenn Bartsch, Grace Peng, Carl Grunfeld.   

Abstract

OBJECTIVE: To assess by race/ethnicity long-term changes in metabolic parameters and body composition among treatment-naive persons initiating antiretroviral therapy (ART).
METHODS: We compared changes in 398 participants (African American n = 243, Latino n = 43, white n = 112) initiating ART. At baseline, 1-month (metabolic parameters only) and 4-month follow-up intervals (anthropometric measurements) were performed and fasting metabolic parameters measured. Rates of change over time and overall mean changes from baseline were compared.
RESULTS: Latinos had the greatest increase in glucose and insulin resistance and greatest loss of mid-arm and mid-thigh subcutaneous tissue areas. On average, mid-arm and mid-thigh nonsubcutaneous tissue areas increased in all races. Waist subcutaneous tissue area decreased only for Latinos. Visceral tissue area increased the most for Latinos and whites. For all groups, the initial increase in high-density lipoprotein cholesterol was sustained. The initial increase in low-density lipoprotein cholesterol was followed by a gradual decline in all groups. Triglycerides increased for all groups; the increase being the least for African Americans.
CONCLUSIONS: In this prospective long-term evaluation, changes in metabolic parameters and body composition varied across race groups. Latinos experienced the most unfavorable changes. Such changes should be monitored over time as the identified differences may impact ART selection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295334     DOI: 10.1097/QAI.0b013e31818ce808

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

Review 1.  Unique aspects of the care of HIV-positive Latino patients living in the United States.

Authors:  Joseph Metmowlee Garland; Adriana S Andrade; Kathleen R Page
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

2.  Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings.

Authors:  Mitch M Matoga; Mina C Hosseinipour; Evgenia Aga; Heather J Ribaudo; Nagalingeswaran Kumarasamy; John Bartlett; Michael D Hughes
Journal:  Antivir Ther       Date:  2016-10-14

3.  HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort study.

Authors:  Matthew J Nicholaou; Jeremy J Martinson; Alison G Abraham; Todd T Brown; Shehnaz K Hussain; Steven M Wolinsky; Lawrence A Kingsley
Journal:  AIDS Res Hum Retroviruses       Date:  2013-03-08       Impact factor: 2.205

4.  Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005.

Authors:  Luis A Cubano; Luz Cumba; Lycely C del Sepúlveda-Torres; Nawal Boukli; Eddy Ríos-Olivares
Journal:  Bol Asoc Med P R       Date:  2010 Jul-Sep

5.  Effects of raltegravir combined with tenofovir/emtricitabine on body shape, bone density, and lipids in African-Americans initiating HIV therapy.

Authors:  Laura Young; David A Wohl; William B Hyslop; Yueh Z Lee; Sonia Napravnik; Aimee Wilkin
Journal:  HIV Clin Trials       Date:  2015-08-07

6.  Prevalence of Drug Resistance and Associated Mutations in a Population of HIV-1(+) Puerto Ricans: 2006-2010.

Authors:  Lycely Del C Sepúlveda-Torres; Alexandra De La Rosa; Luz Cumba; Nawal Boukli; Eddy Ríos-Olivares; Luis A Cubano
Journal:  AIDS Res Treat       Date:  2012-04-24

7.  Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey.

Authors:  Nazisa Hejazi; Roslee Rajikan; Christopher Lee Kwok Choong; Suzana Sahar
Journal:  BMC Public Health       Date:  2013-08-15       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.